677723-35-2

Basic information

• Product Name: 3'-O-(3-benzenesulfonylfuroxan-4-yl)-5'-O-(tert-butyldimethylsilyl)-5-trifluoromethyl-2'-deoxyuridine
• Synonyms: 3'-O-(3-benzenesulfonylfuroxan-4-yl)-5'-O-(tert-butyldimethylsilyl)-5-trifluoromethyl-2'-deoxyuridine
• CAS NO: 677723-35-2
• Molecular Weight: 634.662
• Mol File: 677723-35-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3'-O-(3-benzenesulfonylfuroxan-4-yl)-5'-O-(tert-butyldimethylsilyl)-5-trifluoromethyl-2'-deoxyuridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3'-O-(3-benzenesulfonylfuroxan-4-yl)-5'-O-(tert-butyldimethylsilyl)-5-trifluoromethyl-2'-deoxyuridine(677723-35-2)
• EPA Substance Registry System: 3'-O-(3-benzenesulfonylfuroxan-4-yl)-5'-O-(tert-butyldimethylsilyl)-5-trifluoromethyl-2'-deoxyuridine(677723-35-2)

Safety Data

• Hazardous Substances Data: 677723-35-2(Hazardous Substances Data)

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 70-00-8 2'-deoxy-5-trifluoromethyluridine 
• 127978-84-1 5'-O-(tert-butyldimethylsilyl)-2'-deoxy-5-(trifluoromethyl)uridine 
• 66074-00-8 3,4-bis(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide 

Relevant articles and documents

Design and Synthesis of 3′- and 5′ -O-(3-Benzenesulfonylfuroxan-4-yl)-2′-deoxyuridines: Biological Evaluation as Hybrid Nitric Oxide Donor-Nucleoside Anticancer Agents

A group of 3′-O- and 5′ -O-(3-benzenesulfonylfuroxan-4-yl)-2′-deoxyuridines possessing a variety of substituents (H, Me, I, F, CF3) at the C-5 position of the nucleoside moiety were synthesized for evaluation as hybrid anticancer agents that ha